Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11270758 | 0.96 | — | — | |
| Lithium Ion SCHEMBL384217 | 0.92 | — | — | |
| SCHEMBL108892 | 0.92 | — | — | |
| SCHEMBL15063009 | 0.88 | — | — | |
| SCHEMBL5729396 | 0.88 | — | — | |
| SCHEMBL384218 | 0.88 | — | — | |
| SCHEMBL509640 | 0.88 | — | — | |
| SCHEMBL15016076 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL8853911 | 0.85 | — | — | |
| SCHEMBL732371 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466934-B1 | SULFONAMIDE COMPOUNDS OR SALT THEREOF AS RIBONUCLEOTIDE REDUCTASE INHIBITORS FOR TREATING CANCER | TAIHO PHARMACEUTICAL CO LTD (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-115038753-B | Composition, curable composition, cured product, and storage method | 株式会社钟化 | 2024-03-19 | — | — | CN | disclosed |
| CN-117120454-A | Phosphite compound, process for producing the same, and use thereof | 住友化学株式会社 | 2023-11-24 | — | — | CN | disclosed |
| WO-2023048155-A1 | ONE-PACK TYPE CURABLE COMPOSITION AND CURED PRODUCT | 株式会社カネカ | 2023-03-30 | — | — | WO | disclosed |
| CN-115038753-A | Composition, curable composition, cured product and storage method | 株式会社钟化 | 2022-09-09 | — | — | CN | disclosed |
| CN-109563057-B | Sulfonamide compound or salt thereof | 大鹏药品工业株式会社 | 2022-06-24 | — | — | CN | disclosed |
| EP-3673908-B1 | ANTI-TUMOR EFFECT POTENTIATOR | TAIHO PHARMACEUTICAL CO LTD (JP) | 2022-01-12 | — | — | EP | disclosed |
| CN-108348906-B | Hydrogenation catalyst composition and method for producing same, and hydrogenated polymer and method for producing same | 旭化成株式会社 | 2021-03-30 | — | — | CN | disclosed |
| US-10889555-B2 | Sulfonamide compound or salt thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2021-01-12 | — | — | US | disclosed |
| US-20200405697-A1 | Antitumor Agent | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2020-12-31 | — | — | US | disclosed |
| EP-0054924-A2 | Pharmaceutical compounds, their preparation and use | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-06-30 | — | — | EP | disclosed |
| EP-0032261-A1 | Novel bis- and mono-quaternary ammonium derivatives of 2-beta, 16-beta-dipiperidino-5-alpha-androstanes, processes for their preparation and pharmaceutical preparations | AKZO N.V. (NL) | 1981-07-22 | — | — | EP | disclosed |
| WO-1981001710-A1 | MONO AND BIS PIPERIDINIUM ANDROSTANES DERIVATIVES | AKZO NV (NL) | 1981-06-25 | — | — | WO | disclosed |
| EP-0022229-A1 | Substituted phenol ethers, their preparation, intermediates therefor, pharmaceutical compositions containing them and the preparation thereof | THE WELLCOME FOUNDATION LIMITED (GB) | 1981-01-14 | — | — | EP | disclosed |
| US-4229466-A | TREATING NEPHRITIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1980-10-21 | — | — | US | disclosed |
| EP-0013592-A1 | N,N-disubstituted-aminomethyl-phenylethanolamines and pharmaceutical formulations thereof | PFIZER INC. (US) | 1980-07-23 | — | — | EP | disclosed |
| US-4211794-A | ANTIVIRAL INTERFERON PRODUCTION | PFIZER INC. (US) | 1980-07-08 | — | — | US | disclosed |
| US-4144340-A | ADRENERGIC BLOCKING AGENTS | DEUTSCHE GOLD UND SILBER- SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-03-13 | — | — | US | disclosed |
| US-3981887-A | Sulfoxides and sulfones | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-09-21 | — | — | US | disclosed |
| US-3941775-A | 6-Aza-3H-1,4-benzodiazepines | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-03-02 | — | — | US | disclosed |